How much does Apelis cost and can medical insurance reimburse it?

Alpelisib, also known asAlpelisib, is an innovative targeted therapy designed to treat malignant tumors, especially breast cancer. This drug was approved by the US FDA and has received widespread attention and application worldwide.

The main treatment targets of Apelvis are those patients with advanced or metastatic breast cancer who are hormone receptor positive, human epidermal growth factor receptor2 negative, and carry PIK3CA gene mutations. This patient group faces huge challenges in clinical treatment, and the emergence of apelvis provides them with new treatment opportunities.

The drug’s mechanism of action is to block the growth and spread of cancer cells by inhibiting the activity of thePI3K signaling pathway. This targeted treatment not only improves the therapeutic effect, but also reduces damage to the patient's normal cells, thereby reducing the incidence of side effects.

In clinical studies, the treatment regimen of Apelvis combined with other drugs significantly prolonged the progression-free survival of patients and improved their quality of life. For example, in the SOLAR-1 study when used in combination with fulvestrant, apelvis showed impressive efficacy, giving breast cancer patients greater hope for survival.

Currently, Apelvis is not available in China. Patients in need can only choose to purchase it from overseas or contact regular overseas medical consulting companies. As far as we know, Apelvis has been launched in Hong Kong. The original drug produced by Swiss Novartis Pharmaceuticals is 150mg and 56 capsules, and the price per box is 41,000 yuan. Although the price is higher in Hong Kong, it is also available in the Indian market. The price of 28 tablets of 150mg is 5,080 yuan. In Lucius, Laos, the price has dropped to about 2,500 yuan. If you want to know more about Apelvis, please consult a professional overseas medical consulting company.

In general, apelvis occupies an important position in the field of breast cancer treatment with its unique targeted therapeutic mechanism and significant clinical effects. It not only provides patients with new treatment options, but also opens up new directions for future tumor treatment research.